204
|
|
|
Rohm and Haas Electronic Materials Taiwan Ltd.
|
Taiwan
|
Rohm and Haas International Trading (Shanghai) Co. Ltd.
|
China
|
Rohm and Haas Italia S.r.l.
|
Italy
|
Rohm and Haas Mexico, S. de R.L. de C.V.
|
Mexico
|
Rohm and Haas Quimica Ltda.
|
Brazil
|
Rohm and Haas Shanghai Chemical Industry Co., Ltd.
|
China
|
Rohm and Haas Singapore (Pte.) Ltd.
|
Singapore
|
Rohm and Haas Taiwan, Inc.
|
Taiwan
|
Rohm and Haas Texas Incorporated
|
Texas
|
Rohm and Haas Wood Treatment LLC
|
Delaware
|
Specialty Electronic Materials UK Limited
|
United Kingdom
|
Union Carbide Corporation
|
New York
|
Univation (Zhangjiagang) Chemical Company Limited
|
China
|
Univation Technologies, LLC
|
Delaware
|
Valley Asset Leasing, LLC
|
Delaware
|
Zhejiang OMEX Environmental Engineering Co., Ltd.
|
China
|
Zhejiang Pacific Chemical Corporation
|
China
|
DuPont Subsidiaries
|
Organized Under
Laws Of
|
E.I. du Pont de Nemours and Company
|
Delaware
|
Belco Technologies Corporation
|
Delaware
|
DPC (Luxembourg) SARL
|
Luxembourg
|
DPNL BV
|
The Netherlands
|
Du Pont (Australia) PTY LTD.
|
Australia
|
Du Pont Agricultural Chemicals Ltd., Shanghai
|
China
|
Du Pont China Limited (US)
|
Delaware
|
Du Pont de Nemours (Belgium) BVBA
|
Belgium
|
Du Pont de Nemours Italiana S.r.l.
|
Italy
|
Du Pont Feedstocks Company
|
Delaware
|
DuPont (China) Research & Development and Management Co., Ltd.
|
China
|
DuPont (Korea) Inc.
|
Korea
|
DuPont (Thailand) Limited
|
Thailand
|
DuPont (U.K.) Industrial Limited
|
United Kingdom
|
DuPont (U.K.) Limited
|
United Kingdom
|
DuPont (U.K.) Ltd.
|
United Kingdom
|
DuPont Acquisition (Luxembourg) S.a.r.l.
|
Luxembourg
|
DuPont Acquisition, LLC
|
Delaware
|
DuPont Apollo (Shenzhen) Limited
|
China
|
DuPont Argentina S.R.L.
|
Argentina
|
DuPont Asturias, S.L.
|
Spain
|
DuPont Belgium North America Finance Company
|
Belgium
|
DuPont BVco BV
|
The Netherlands
|
DuPont Capital Management Corporation
|
Delaware
|
DuPont Chemical and Energy Operations, Inc.
|
Delaware
|
DuPont China Holding Company Ltd.
|
China
|
DuPont China Limited
|
Hong Kong
|
DuPont Company (Singapore) Pte Ltd.
|
Singapore
|
DuPont Contern (Luxembourg) SARL
|
Luxembourg
|
DuPont Coordination Center N.V.
|
Belgium
|
DuPont DACI Beteiligungs-GmbH
|
Austria
|
DuPont de Nemours (Deutschland) GmbH
|
Germany
|
DuPont de Nemours (France) S.A.S.
|
France
|
DuPont de Nemours (Luxembourg) S.a.r.l.
|
Luxembourg
|
DuPont de Nemours (Luxembourg) SARL
|
Luxembourg
|
205
|
|
|
DuPont de Nemours (Nederland) B.V.
|
The Netherlands
|
DuPont de Nemours Groupe SAS
|
France
|
DuPont de Nemours Holding Sarl (LLC)
|
Switzerland
|
DuPont de Nemours International S.a.r.l.
|
Switzerland
|
DuPont de Nemours International Sarl
|
Switzerland
|
DuPont Denmark Holding ApS
|
Denmark
|
DuPont Deutschland Holding GmbH & Co. KG
|
Germany
|
DuPont do Brasil S.A.
|
Brazil
|
DuPont Eastern Europe BV
|
The Netherlands
|
DuPont Electronic Polymers LP
|
Delaware
|
DuPont Electronics Microcircuits Industries, Ltd.
|
Bermuda
|
DuPont Energy Company, LLC
|
Delaware
|
DuPont Global Operations, Inc.
|
Delaware
|
DuPont Iberica, S.L.
|
Spain
|
DuPont International (Luxembourg) SCA
|
Luxembourg
|
DuPont International B.V.
|
The Netherlands
|
DuPont International Operations S.a r.l.
|
Switzerland
|
DuPont Kabushiki Kaisha
|
Japan
|
DuPont KGA B.V.
|
The Netherlands
|
DuPont Mexico S.A. de C.V.
|
Mexico
|
DuPont Nutrition Biosciences ApS
|
Denmark
|
DuPont Nutrition USA, Inc.
|
Delaware
|
DuPont Operations Worldwide, Inc.
|
Delaware
|
DuPont Operations, Inc.
|
Delaware
|
DuPont Products (Luxembourg) SARL
|
Luxembourg
|
DuPont Science (Luxembourg) S.a r.l.
|
Luxembourg
|
DuPont Solutions (Luxembourg) SARL
|
Luxembourg
|
DuPont Specialty Products Kabushiki Kaisha
|
Japan
|
DuPont Taiwan Limited
|
Taiwan
|
DuPont Technology (Luxembourg) S.a.r.l.
|
Luxembourg
|
DuPont Teijin Films China LTD.
|
Hong Kong
|
DuPont Trading (Shanghai) Co., Ltd.
|
China
|
DuPont Xingda Filaments Company Limited
|
China
|
E.I. DuPont Canada Company
|
Canada
|
E.I. DuPont Canada- Thetford Inc.
|
Canada
|
E.I. DuPont India Private Limited
|
India
|
EKC Technology, Inc.
|
California
|
FCC Acquisition Corporation
|
California
|
FMC Biopolymer AS
|
Norway
|
FMC Manufacturing Limited
|
Ireland
|
Hickory Holdings, Inc.
|
Delaware
|
Howson Algraphy BV
|
The Netherlands
|
MECS Inc.
|
Delaware
|
Pioneer Hi-Bred International, Inc.
|
Iowa
|
Shenzhen DuPont Performance Materials Investment Co., Ltd.
|
China
|
Solae L.L.C.
|
Delaware
|
SP EMEA Holding 7 B.V.
|
The Netherlands
|
SP Luxembourg, LLC
|
Delaware
|
Spruance Genco, LLC
|
Delaware
|
Subsidiaries not listed would not, if considered in the aggregate as a single subsidiary, constitute a significant subsidiary.
206
|
|
|
|
|
Consent of Independent Registered Public Accounting Firm
|
EXHIBIT 23.1
|
|
|
|
We consent to the incorporation by reference in Registration Statements No. 333-220324 and 333-220330 on Forms S-8 of our reports dated February 15, 2018, relating to (1) the consolidated financial statements and financial statement schedule of DowDuPont Inc. and subsidiaries (the “Company”), (which report expresses an unqualified opinion on those financial statements and financial statement schedule and includes an explanatory paragraph regarding a change in accounting policy related to asbestos-related defense and processing costs and an emphasis of a matter paragraph regarding the merger of The Dow Chemical Company and E. I. du Pont de Nemours and Company), and (2) the effectiveness of the Company's internal control over financial reporting as of December 31, 2017, appearing in this Annual Report on Form 10-K of DowDuPont Inc. for the year ended December 31, 2017.
|
|
/s/ DELOITTE & TOUCHE LLP
|
Deloitte & Touche LLP
|
Midland, Michigan
|
February 15, 2018
|
207
|
|
|
|
|
Consent of Independent Registered Public Accounting Firm
|
EXHIBIT 23.2
|
|
|
|
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8s (Nos. 333-220330 and 333-220324) of DowDuPont Inc. of our Successor report dated February 15, 2018 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting of E. I du Pont de Nemours and Company, which appears in this Annual Report on Form 10-K of DowDuPont Inc.
|
|
/s/ PRICEWATERHOUSECOOPERS LLP
|
PricewaterhouseCoopers LLP
|
Philadelphia, Pennsylvania
|
February 15, 2018
|
208
|
|
|
|
|
Ankura Consulting Group, LLC's Consent
|
EXHIBIT 23.3
|
|
|
|
DowDuPont Inc.:
Ankura Consulting Group, LLC ("Ankura") hereby consents to the use of Ankura's name and the reference to Ankura's reports in this Annual Report on Form 10-K of DowDuPont Inc. for the year ended December 31, 2017 , and the incorporation by reference thereof in the following Registration Statements of DowDuPont Inc.:
|
|
|
Form S-8:
|
|
|
|
Nos.
|
333-220330
|
|
333-220324
|
|
|
/s/ B. THOMAS FLORENCE
|
B. Thomas Florence
|
Senior Managing Director
|
Ankura Consulting Group, LLC
|
February 15, 2018
|
209
|
|
|
|
|
|
|
|
DowDuPont Inc.
|
|
EXHIBIT 31.1
|
|
|
|
|
|
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Edward D. Breen, certify that:
|
|
1.
|
I have reviewed this annual report on Form 10-K of DowDuPont Inc.;
|
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
|
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
|
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
|
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 15, 2018
|
|
/s/ EDWARD D. BREEN
|
Edward D. Breen
|
Chief Executive Officer
|
Dostları ilə paylaş: |